AEON Biopharma, Inc. Announces Closing of $20.0 Million Underwritten Public Offering
Inc. (NYSE: AEON) (the “Company”), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a 351(k) biosimilar pathway, today announced the closing of its ...
Trust Stamp Announces Pricing of $3.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Atlanta, GA, Jan. 07, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: IDAI), a global provider of AI-powered technologies, today announced that it has entered into a securities purchase agreement with a single ...
Amesite Down 15% Following News of Public Offering
Shares of Amesite were down 15% to $3.45 in after-hours trading Monday following an announcement of a public offering. In a prospectus supplement, the company reiterated that there is substantial ...
Amesite Announces Proposed Public Offering
Amesite Inc. (Nasdaq: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, today announced that it intends to offer and sell shares ...
manilatimes17h
HWH International Inc. Announces Closing of Approximately $1.76 Million Public Offering at $0.40 per Share
HWH International Inc. (the "Company”) (NASDAQ: HWH), a purpose-driven lifestyle company, today announced the closing of its ...
AEON Biopharma, Inc. Announces Pricing of Approximately $20.0 Million Underwritten Public Offering
Aegis Capital Corp. is acting as the sole book-running manager for the Offering on a firm commitment basis. Sichenzia Ross Ference Carmel LLP is acting as counsel to the Company. Kaufman & Canoles, ...